Pfizer Ltd

₹ 5,783 1.19%

03 Jul - close price

About

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.^[1]
It is the 3rd largest multinational pharmaceutical company in India.^[2]

Key Points

Parentage
The company is a subsidiary of Pfizer Inc. one of the world’s leading biopharma companies with a presence in over 125 countries. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. ^[1] ^[2]

Website BSE NSE

Market Cap ₹ 26,459 Cr.
Current Price ₹ 5,783
High / Low ₹ 6,453 / 3,701
Stock P/E 41.3
Book Value ₹ 922
Dividend Yield 0.61 %
ROCE 21.6 %
ROE 16.4 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company has been maintaining a healthy dividend payout of 66.5%

Cons

The company has delivered a poor sales growth of 1.18% over past five years.
Earnings include an other income of Rs.344 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap BSE 250 SmallCap Index BSE 400 MidSmallCap Index Nifty MidSmallcap 400 Nifty Smallcap 250 Nifty 500 Multicap 50:25:25 Nifty Total Market Nifty MidSmall Healthcare Nifty Smallcap250 Quality 50 Nifty500 Equal Weight

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	550	593	637	622	573	531	575	540	547	563	589	538	592
	384	401	406	418	391	421	393	387	357	385	399	392	364
Operating Profit	165	192	232	203	182	111	183	153	189	177	189	146	228
OPM %	30%	32%	36%	33%	32%	21%	32%	28%	35%	32%	32%	27%	38%
	17	-118	213	27	12	33	36	44	75	42	43	43	217
Interest	4	4	3	4	3	3	3	3	7	2	2	2	3
Depreciation	34	27	26	26	26	16	15	18	14	15	15	15	16
Profit before tax	145	43	415	201	165	126	201	176	244	203	215	172	426
Tax %	13%	25%	25%	25%	21%	26%	26%	26%	27%	26%	26%	26%	22%
	126	33	311	151	130	94	149	130	179	151	158	128	331
EPS in Rs	27.50	7.12	68.00	32.93	28.34	20.44	32.56	28.41	39.10	32.94	34.61	27.89	72.34
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	1,112	1,853	2,012	1,966	1,969	2,082	2,152	2,239	2,611	2,425	2,193	2,281
	872	1,438	1,579	1,616	1,468	1,516	1,578	1,526	1,775	1,616	1,555	1,540
Operating Profit	239	414	433	350	501	566	574	712	836	809	638	742
OPM %	22%	22%	22%	18%	25%	27%	27%	32%	32%	33%	29%	33%
	109	44	97	232	114	167	183	81	63	134	185	344
Interest	1	2	1	2	1	2	11	15	11	13	15	8
Depreciation	8	250	58	63	66	71	103	109	115	106	62	61
Profit before tax	340	207	470	517	548	660	642	669	773	824	746	1,016
Tax %	35%	66%	35%	35%	34%	35%	21%	26%	21%	24%	26%	24%
	221	70	305	337	360	429	509	498	613	624	551	768
EPS in Rs	74.01	15.26	66.67	73.62	78.71	93.79	111.29	108.77	133.90	136.38	120.52	167.79
Dividend Payout %	486%	82%	22%	27%	25%	24%	297%	32%	26%	51%	29%	119%

Compounded Sales Growth
10 Years:	2%
5 Years:	1%
3 Years:	-4%
TTM:	4%

Compounded Profit Growth
10 Years:	20%
5 Years:	5%
3 Years:	2%
TTM:	17%

Stock Price CAGR
10 Years:	11%
5 Years:	7%
3 Years:	12%
1 Year:	26%

Return on Equity
10 Years:	16%
5 Years:	18%
3 Years:	17%
Last Year:	16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	30	46	46	46	46	46	46	46	46	46	46	46
Reserves	629	1,927	2,118	2,373	2,637	2,966	3,350	2,347	2,819	3,162	3,550	4,172
	0	2	2	2	2	2	2	63	39	41	40	41
	318	638	722	840	1,004	926	1,007	810	997	752	593	653
Total Liabilities	977	2,614	2,888	3,261	3,690	3,940	4,405	3,266	3,901	4,001	4,229	4,911
	20	944	925	902	950	886	973	894	869	749	713	724
CWIP	3	13	3	15	1	0	1	3	1	8	0	8
Investments	44	43	37	0	0	0	0	0	0	0	0	0
	909	1,614	1,923	2,343	2,739	3,054	3,432	2,369	3,030	3,244	3,516	4,180
Total Assets	977	2,614	2,888	3,261	3,690	3,940	4,405	3,266	3,901	4,001	4,229	4,911

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	132	113	345	329	332	98	323	427	667	356	257	660
	103	68	-701	-250	-238	35	1,530	-469	-575	-36	54	-71
	-1,360	-1	-62	-83	-110	-110	-164	-1,571	-181	-346	-235	-205
Net Cash Flow	-1,125	181	-417	-3	-17	23	1,690	-1,613	-88	-26	75	383

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	57	32	26	20	29	30	29	18	20	23	31	31
Inventory Days	148	191	167	148	147	189	198	199	173	175	200	214
Days Payable	156	165	157	178	245	213	197	130	102	91	77	68
Cash Conversion Cycle	49	58	36	-10	-69	6	31	87	91	107	154	177
Working Capital Days	25	7	-9	-46	-57	-15	-7	13	-8	3	31	29
ROCE %	29%	24%	22%	17%	21%	23%	20%	23%	29%	26%	22%	22%

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%
	2.55%	2.55%	2.77%	2.80%	2.81%	2.82%	3.03%	3.32%	3.22%	3.54%	2.74%	2.18%
	14.83%	14.88%	14.93%	14.89%	14.89%	15.00%	15.15%	15.32%	15.83%	16.03%	16.80%	17.10%
	18.70%	18.65%	18.39%	18.38%	18.37%	18.24%	17.87%	17.42%	17.00%	16.50%	16.54%	16.79%
No. of Shareholders	1,23,449	1,22,028	1,17,950	1,17,194	1,15,988	1,16,948	1,12,456	1,09,214	1,06,098	98,824	1,05,015	1,08,261

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%
	2.89%	3.01%	4.20%	3.69%	1.89%	2.20%	2.80%	3.32%	2.18%
	10.53%	11.91%	11.98%	12.66%	14.63%	15.06%	14.89%	15.32%	17.10%
	22.66%	21.16%	19.90%	19.73%	19.55%	18.82%	18.38%	17.42%	16.79%
No. of Shareholders	85,570	72,919	76,717	82,750	1,45,980	1,25,287	1,17,194	1,09,214	1,08,261

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Concalls

Aug 2020
Transcript
PPT
May 2017
Transcript
PPT
Feb 2017
Transcript
PPT
Nov 2016
Transcript
PPT
Aug 2016
Transcript
PPT
May 2016
Transcript
PPT
Feb 2016
Transcript
PPT